FOLH1 and prostate cancer: A total of 302 men (with biopsy-proven prostate cancer and high-risk features at ten hospitals in Australia) were randomly assigned. A total of 152 (50%) men were randomly assigned to conventional imaging and 150 (50%) to PSMA PET-CT.